{"organizations": [], "uuid": "6a752009a19a56368fbe2267ef78e7b245c0b570", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-10736/social", "site_section": "https://www.wsj.com/news/markets", "section_title": "Stock Market &amp; Finance News - Wall Street Journal", "url": "https://www.wsj.com/articles/investors-brace-yourselves-for-more-drug-price-drama-1526463001", "country": "US", "domain_rank": 387, "title": "Investors, Brace Yourselves for More Drug-Price Drama", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.165, "site_type": "news", "published": "2018-05-16T13:30:00.000+03:00", "replies_count": 0, "uuid": "6a752009a19a56368fbe2267ef78e7b245c0b570"}, "author": "Charley Grant", "url": "https://www.wsj.com/articles/investors-brace-yourselves-for-more-drug-price-drama-1526463001", "ord_in_thread": 0, "title": "Investors, Brace Yourselves for More Drug-Price Drama", "locations": [], "entities": {"persons": [{"name": "trump", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "The next leg of the Trump administrationâ€™s plan to lower the cost of drug prices could get ugly for investors.\nAs soon as Thursday the Food and Drug Administration plans to publish a database of complaint letters from generic drug companies to the agency alleging anticompetitive activities from branded pharmaceutical companies. It is likely that some complaints will pertain to high-price blockbuster drugs that investors watch most closely.\n... To Read the Full Story Subscribe Sign In", "external_links": [], "published": "2018-05-16T13:30:00.000+03:00", "crawled": "2018-05-16T17:29:06.000+03:00", "highlightTitle": ""}